The global zinc methionine chelates market size was valued at USD 11.5 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 6.7% from 2020 to 2027. Growing consumer awareness regarding the nutritional requirements and deficiencies in animals is expected to propel the consumption of feed additives, which, in turn, is expected to drive the demand for zinc methionine chelates. Trace minerals such as zinc and amino acids are the key raw materials used in the production of chelates. +Zinc is one of the major minerals used in animal feed. It helps in protein synthesis and plays an important role in enhancing the properties of defense enzymes. However, zinc deficiency in animals may lead to poor growth, loss of appetite, and low reproduction rate. Rising consumption of meat and meat products has propelled the manufacturers to source disease-free and superior quality raw materials. This, in turn, has generated a need to focus on the overall health and development of animals.
Also, a frequent outbreak of diseases such as bird flu and foot-and-mouth disease among animals and poultry leads to their reduced performance, reproduction activities, and high mortality. The aforementioned factors are anticipated to drive the demand for animal feed additives, which, in turn, is expected to drive the demand for zinc methionine chelates over the forecast period. Key players operating in the market for zinc methionine chelates are involved in R&D activities to improve product quality and reduce the cost of the final product. Increasing preference for natural and organic feed products among feed manufacturers is an evolving trend and is further anticipated to drive the market for zinc methionine chelates.
Swine accounted for the largest revenue share of 45.1% in the livestock segment in 2019. Growing consumption of pork meat has compelled the manufacturers to produce high-quality, disease-free meat products for human consumption. This has given rise to the need for feed additives. Zinc methionine chelates are normally used as additives in swine feed or included in dietary supplement formulation in order to ensure proper growth and improve the reproductive health in animals. In addition, zinc chelates improve animal health and reduce the mortality rate in animals.
Rising consumption of fish and fish products has led to increased demand for high-quality and disease-free products. This is expected to drive the demand for aquafeed additives, which, in turn, is expected to boost the consumption for zinc methionine chelates in feed formulations. In addition, the flourishing aquaculture industry worldwide, due to the consumption of marine food products such as prawns and shrimps, is expected to fuel the demand for chelates over the forecast period. Zinc methionine chelates, when used as feed additives, reduce scaling and fouling, promote effective and healthy growth, and provide essential nutrients required for proper body function.
A significant amount of chelated minerals is used in pet food formulations. Rising pet adoptions along with growing consumer awareness towards the nutritional requirements of pets are driving the demand for organic and naturally derived as well as nutritional pet food products. This is expected to drive the demand for functional feed ingredients in pet foods, which, in turn, is expected to drive the zinc methionine chelates market over the period. Pet food manufacturers include mineral salts such in combination with amino acids in the form of zinc chelate, as supplements in their products.
Asia Pacific accounted for a revenue share of over 34.0% in 2019 in the market for zinc methionine chelates. Increased consumer spending, growing consumption of animal products, and flourishing animal feed industry are expected to drive the market for zinc methionine chelates in the region. Increasing production and exports of feed additives in the region from key countries such as China and Japan are anticipated to contribute to market growth. Zinc methionine chelates are primarily used to enhance health, increase reproduction rate, and reduce the occurrence of several diseases in animals.
Growing consumption of meat and meat products in the region has generated a need to focus on animal health and hygiene, which, in turn, has given rise to the demand for feed additives. Thus, a rise in the demand for feed additives is likely to boost the growth of the market for zinc methionine chelates in the region.
In Europe, countries including Germany, France, and Italy have observed a surge in meat consumption over the past few years, which has propelled manufacturers to source disease-free and high-quality animal products. Further, the rising demand for high-quality meat and meat products is anticipated to drive the feed additives market in the region. This, in turn, is expected to fuel the consumption of zinc methionine chelates in the feed additives industry.
Besides, a notable demand for chelated minerals is witnessed from the aquaculture industry in the region. This can be attributed to the high consumption of seafood products such as fish, lobsters, crabs, and prawns. The rising income levels of consumers and the increasing consumption of seafood are the factors responsible for propelling the demand for aquaculture in France.
Key players operating in the market for zinc methionine chelates have a long-term presence and possess a substantial share in the industry. They are focused on backward integration to broaden their product portfolios as well as improve and control the quality of the final product. Backward integration in the value chain may result in improved profit margins for manufacturers owing to their ability to produce high-grade additives along with reduced distribution cost and better control over the product prices. Some of the prominent players in the zinc methionine chelates market include:
Titan Biotech Ltd.
JH Biotech Inc.
Chengdu Chelation Biology Technology Co., Ltd.
Market size value in 2020
USD 12.4 million
Revenue forecast in 2027
USD 19.3 million
CAGR of 6.7% from 2020 to 2027
Base year for estimation
2016 - 2018
2020 - 2027
Revenue in USD thousand and CAGR from 2020 to 2027
Revenue forecast, company share, competitive landscape, growth factors and trends
North America; Europe; Asia Pacific; Central & South America; Middle East & Africa
The U.S.; Canada; Mexico; Germany; Spain; The U.K.; France; Italy; China; Japan; India; Australia; Vietnam; Indonesia; Brazil; Argentina; South Africa; Saudi Arabia
Key companies profiled
Zinpro Corporation; NOVUS INTERNATIONAL; UNO VETCHEM; Titan Biotech Ltd.; JH Biotech Inc.; Balchem Inc.; Chengdu Chelation Biology Technology Co., Ltd.
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global zinc methionine chelates market report on the basis of livestock and region:
Livestock Outlook (Revenue, USD Thousand, 2016 - 2027)
Regional Outlook (Revenue, USD Thousand, 2016 - 2027)
Central & South America
Middle East & Africa
b. The global zinc methionine chelates market size was estimated at USD 11.5 million in 2019 and is expected to reach USD 12.4 million in 2020.
b. The global zinc methionine chelates market is expected to grow at a compound annual growth rate of 6.7% from 2020 to 2027 to reach USD 19.3 million by 2027.
b. North America dominated the zinc methionine chelates market with a share of 28.9% in 2019. This is attributable to rising healthcare awareness coupled with cloud-based technologies acceptance and constant research and development initiatives.
b. Some key players operating in the zinc methionine chelates market include Teladoc; Doctor on Demand; iCliniq; IBM; Intel Corporation; Philips Healthcare; McKesson Corporation; AMD Telemedicine; GE Healthcare; CardioNet Inc.; 3m Health Information Systems; Medic4all; CirrusMD Inc.; Cisco; and American Telecare Inc.
b. Key factors that are driving the market growth include increasing medicare reimbursement for telehealth services, reducing emergency room visits and hospitalization rate, and technological innovation in communication technology across the world.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."